Macquarie Healthcare Fund Class R (DLRHX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
22.20
+0.13 (0.59%)
Jun 2, 2025, 4:00 PM EDT
-15.88% (1Y)
Fund Assets | 934.76M |
Expense Ratio | 1.46% |
Min. Investment | $0.00 |
Turnover | n/a |
Dividend (ttm) | 3.26 |
Dividend Yield | 14.75% |
Dividend Growth | 133.67% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 3, 2024 |
Previous Close | 22.07 |
YTD Return | -3.60% |
1-Year Return | -4.45% |
5-Year Return | 20.65% |
52-Week Low | 20.83 |
52-Week High | 29.58 |
Beta (5Y) | n/a |
Holdings | 112 |
Inception Date | Jan 28, 2010 |
About DLRHX
DLRHX was founded on 2010-01-28. The Fund's investment strategy focuses on Health/Biotech with 1.52% total expense ratio. Delaware Group Equity Funds IV: Delaware Healthcare Fund; Class R Shares seeks maximum long-term capital growth through capital appreciation. Normally, the Fund will invest at least 80% of its assets in the equity securities of healthcare companies, meaning companies that develop, produce or distribute products or services (the "80% policy").
Category Health
Stock Exchange NASDAQ
Ticker Symbol DLRHX
Share Class Class R
Index Russell 3000 Healthcare TR
Performance
DLRHX had a total return of -4.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.78%.
Top 10 Holdings
46.98% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 9.90% |
Boston Scientific Corporation | BSX | 5.66% |
UnitedHealth Group Incorporated | UNH | 4.23% |
Chugai Pharmaceutical Co., Ltd. | 4519 | 4.16% |
Regeneron Pharmaceuticals, Inc. | REGN | 4.08% |
Pfizer Inc. | PFE | 4.05% |
Elevance Health, Inc. | ELV | 3.84% |
Merck & Co., Inc. | MRK | 3.83% |
AbbVie Inc. | ABBV | 3.68% |
Roche Holding AG | ROG | 3.55% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 3, 2024 | $3.26278 | Dec 4, 2024 |
Dec 4, 2023 | $1.39633 | Dec 5, 2023 |
Dec 2, 2022 | $2.274 | Dec 5, 2022 |
Dec 3, 2021 | $1.476 | Dec 6, 2021 |
Dec 4, 2020 | $1.496 | Dec 7, 2020 |
Dec 5, 2019 | $2.015 | Dec 6, 2019 |